Trial NCT04354259
Publication Feld JJ, medRxiv, 2020
Primary outcome on the report: Proportion of individuals with a negative MT swab for SARS-CoV-2 at Day 7; Incidence of treatment-emergent severe adverse events (SAEs) by Day 14